Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine cervix

Cancer Letters

Volumn 210, Issue 1, 2004, Pages 57-62

  Minaguchi, Takeo ^a   Yoshikawa, Hiroyuki ^b   Nakagawa, Shunsuke ^a   Yasugi, Toshiharu ^a   Yano, Tetsu ^a   Iwase, Haruko ^c   Mizutani, Katsumi ^c   Shiromizu, Kenji ^d   Ohmi, Kazuo ^e   Watanabe, Yoh ^f   Noda, Kiichiro ^f   Nishiu, Mieko ^g   Nakamura, Yusuke ^g   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d SAITAMA CANCER CENTER   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL   (Japan)

^f KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cervical Adenocarcinoma; HPV; Mutation; PTEN

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; VIRUS DNA;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENDOMETRIOID CARCINOMA; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN TISSUE; MOLECULAR BIOLOGY; MUCINOUS CARCINOMA; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VERRUCA VULGARIS; WART VIRUS; WILD TYPE;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, ENDOMETRIOID; DNA, VIRAL; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MIDDLE AGED; MUTATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 2542486388     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.03.017     Document Type: Article

References (35)

1. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., et al. PTEN putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 275:1997;1943-1947
2. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K., Lin H., Ligon A.H., et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15:1997;356-362
3. Liaw D., Marsh D.J., Li J., Dahia P.L., Wang S.I., Zheng Z., et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16:1997;64-67
4. Marsh D.J., Dahia P.L., Zheng Z., Liaw D., Parsons R., Gorlin R.J., Eng C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet. 16:1997;333-334
5. Tashiro H., Blazes M.S., Wu R., Cho K.R., Bose S., Wang S.I., et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 57:1997;3935-3940
6. Risinger J.I., Hayes A.K., Berchuck A., Barrett J.C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res. 57:1997;4736-4738
7. Kong D., Suzuki A., Zou T.T., Sakurada A., Kemp L.W., Wakatsuki S., et al. PTEN is frequently mutated in primary endometrial carcinomas. Nat. Genet. 17:1997;143-144
8. Cairns P., Okami K., Halachmi S., Halachmi N., Esteller M., Herman J.G., Jen J., Isaacs W.B., Bova G.S., Sidransky D. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res. 57:1997;4997-5000
9. Guldberg P., thor Straten P., Birck A., Ahrenkiel V., Kirkin A.F., Zeuthen J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res. 57:1997;3660-3663
10. Di A. Cristofano and P.P. Pandolfi, The multiple roles of PTEN in tumor suppression. Cell. 100:2000;387-390
11. Risinger J.I., Hayes K., Maxwell G.L., Carney M.E., Dodge R.K., Barret J.C., Berchuck A. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin. Cancer Res. 4:1998;3005-3010
12. Maxwell G.L., Risinger J.I., Hayes K.A., Alvarez A.A., Dodge R.K., Barret J.C., Berchuck A. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers. Clin. Cancer Res. 6:2000;2999-3005
13. Obata K., Morland S.J., Watson R.H., Hitchcock A., Chenevix-Trench G., Thomas E.J., Campbell I.G. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res. 58:1998;2095-2097
14. Sato N., Tsunoda H., Nishida M., Morishita Y., Takimoto Y., Kubo T., Noguchi M. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res. 60:2000;7052-7056
15. Jones M.H., Koi S., Fujimoto I., Hasumi K., Kato K., Nakamura Y. Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p. Genes Chromosomes Cancer. 9:1994;119-123
16. Mitra A.B., Murty V.V., Li R.G., Pratap M., Luthra U.K., Chaganti R.S. Allelotype analysis of cervical carcinoma. Cancer Res. 54:1994;4481-4487
17. Su T.H., Chang J.G., Perng L.I., Chang C.P., Wei H.J., Wang N.M., Tsai C.H. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer. Gynecol. Oncol. 76:2000;193-199
18. Paquette R.L., Lee Y.Y., Wilczynski S.P., Karmakar A., Kizaki M., Miller C.W., Koeffler H.P. Mutations of p53 and human papillomavirus infection in cervical carcinoma. Cancer. 72:1993;1272-1280
19. Dyson N., Howley P.M., Munger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243:1989;934-937
20. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136
21. Werness B.A., Levine A.J., Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 248:1990;76-79
22. Jiko K., Tsuda H., Sato S., Hirohashi S. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus. Int. J. Cancer. 59:1994;601-606
23. Iwasawa A., Nieminen P., Lehtinen M., Paavonen J. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer. 77:1996;2275-2279
24. Tenti P., Romagnoli S., Silini E., Zappatore R., Spinillo A., Giunta P., et al. Human papillomavirus types 16 and 18 infection in infiltrating adenocarcinoma of the cervix: PCR analysis of 138 cases and correlation with histologic type and grade. Am. J. Clin. Pathol. 106:1996;52-56
25. Hording U., Teglbjaerg C.S., Visfeldt J., Bock J.E. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Gynecol. Oncol. 46:1992;313-316
26. Hatch K.D., Fu Y.S. Cervical and vaginal cancer. Berek J.S., Adashi E.Y., Hillard P.A. Novak's gynecology. twelfth ed. 1996;1134-1135 Williams and Wilkins, Baltimore
27. Minaguchi T., Kanamori Y., Matsushima M., Yoshikawa H., Taketani Y., Nakamura Y. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res. 58:1998;4585-4586
28. Minaguchi T., Yoshikawa H., Oda K., Ishino T., Yasugi T., Onda T., et al. PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas. Clin. Cancer Res. 7:2001;2636-2642
29. Soong R., Iacopetta J. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors. Mod. Pathol. 10:1997;252-258
30. Tsuda H., Takarabe T., Okada S., Uchida H., Kasamatsu T., Yamada T., et al. Different pattern of loss of heterozygosity among endocervical-type adenocarcinoma, endometrioid-type adenocarcinoma and adenoma malignum of the uterine cervix. Int. J. Cancer. 98:2002;713-717
31. Sano T., Lin H., Chen X., Langford L.A., Koul D., Bondy M.L., et al. Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res. 59:1999;1820-1824
32. McMenamin M.E., Soung P., Perera S., Kaplan I., Loda M., Sellers W.R. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res. 59:1999;4291-4296
33. Harima Y., Sawada S., Nagata K., Sougawa M., Ostapenko V., Ohnishi T. Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy. Int. J. Oncol. 18:2001;493-497
34. Bauknecht T., See R.H., Shi Y. A novel C/EBP beta-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region. J. Virol. 70:1996;7695-7705
35. Bauknecht T., Shi Y. Overexpression of C/EBPbeta represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-binding protein. J. Virol. 72:1998;2113-2124